Intra-Cellular Therapies IncNASDAQ:ITCI
- LAST PRICE57.0900
- TODAY'S CHANGE (%)1.9200 (3.4802%)
- Bid / Lots51.5000/ 3
- Ask / Lots58.0000/ 4
- Open / Previous Close54.5000 / 55.1700
- Day Range
- 52 Week Range
- Volume475,279
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ITCI |
|---|---|---|
| 09:32 ET | 25193 | 53.64 |
| 09:34 ET | 2400 | 53.795 |
| 09:36 ET | 800 | 53.81 |
| 09:38 ET | 4254 | 53.7681 |
| 09:39 ET | 1311 | 54.07 |
| 09:41 ET | 800 | 54.2 |
| 09:43 ET | 829 | 54.56 |
| 09:45 ET | 200 | 54.45 |
| 09:48 ET | 900 | 54.86 |
| 09:50 ET | 1001 | 54.88 |
| 09:52 ET | 100 | 54.54 |
| 09:54 ET | 1613 | 54.735 |
| 09:56 ET | 100 | 54.65 |
| 09:57 ET | 100 | 54.67 |
| 10:03 ET | 1106 | 54.41 |
| 10:06 ET | 300 | 54.3 |
| 10:08 ET | 2008 | 54.69 |
| 10:10 ET | 647 | 54.95 |
| 10:12 ET | 700 | 55.02 |
| 10:14 ET | 101 | 54.88 |
| 10:17 ET | 4701 | 54.86 |
| 10:19 ET | 252 | 55.14 |
| 10:21 ET | 1201 | 55.005 |
| 10:24 ET | 793 | 54.93 |
| 10:26 ET | 100 | 54.74 |
| 10:28 ET | 100 | 54.74 |
| 10:30 ET | 1200 | 54.45 |
| 10:32 ET | 401 | 54.46 |
| 10:33 ET | 1586 | 54.26 |
| 10:35 ET | 1400 | 54.56 |
| 10:39 ET | 400 | 54.444 |
| 10:44 ET | 910 | 54.41 |
| 10:46 ET | 300 | 54.21 |
| 10:48 ET | 7113 | 54.2399 |
| 10:50 ET | 607 | 54.455 |
| 10:51 ET | 100 | 54.56 |
| 10:53 ET | 600 | 54.66 |
| 10:55 ET | 200 | 54.565 |
| 10:57 ET | 501 | 54.46 |
| 11:00 ET | 400 | 54.55 |
| 11:02 ET | 300 | 54.41 |
| 11:04 ET | 200 | 54.33 |
| 11:08 ET | 600 | 54.41 |
| 11:09 ET | 113 | 54.465 |
| 11:11 ET | 500 | 54.36 |
| 11:13 ET | 900 | 54.49 |
| 11:18 ET | 200 | 54.52 |
| 11:20 ET | 1713 | 54.52 |
| 11:22 ET | 100 | 54.55 |
| 11:24 ET | 604 | 54.53 |
| 11:27 ET | 105 | 54.53 |
| 11:29 ET | 460 | 54.58 |
| 11:31 ET | 100 | 54.53 |
| 11:33 ET | 3954 | 54.745 |
| 11:36 ET | 2204 | 54.93 |
| 11:38 ET | 409 | 54.79 |
| 11:42 ET | 7614 | 54.98 |
| 11:44 ET | 1400 | 54.9 |
| 11:45 ET | 300 | 55.02 |
| 11:47 ET | 200 | 55.04 |
| 11:49 ET | 500 | 54.9 |
| 11:54 ET | 250 | 54.914 |
| 11:56 ET | 2100 | 55.06 |
| 11:58 ET | 1590 | 55.165 |
| 12:00 ET | 500 | 55.08 |
| 12:02 ET | 200 | 55.1 |
| 12:03 ET | 3508 | 55.0075 |
| 12:05 ET | 1750 | 55.3092 |
| 12:07 ET | 850 | 55.29 |
| 12:09 ET | 515 | 55.31 |
| 12:12 ET | 400 | 55.35 |
| 12:14 ET | 2633 | 55.08 |
| 12:16 ET | 100 | 55.09 |
| 12:18 ET | 400 | 55 |
| 12:20 ET | 2600 | 55.01 |
| 12:21 ET | 800 | 54.88 |
| 12:23 ET | 400 | 55.07 |
| 12:25 ET | 1201 | 55.22 |
| 12:27 ET | 903 | 55.31 |
| 12:30 ET | 1700 | 55.2 |
| 12:32 ET | 200 | 55.25 |
| 12:34 ET | 1200 | 55.24 |
| 12:36 ET | 499 | 55.12 |
| 12:38 ET | 500 | 55.05 |
| 12:39 ET | 670 | 55.14 |
| 12:41 ET | 400 | 55.1 |
| 12:45 ET | 400 | 55.07 |
| 12:48 ET | 900 | 54.99 |
| 12:50 ET | 244 | 54.98 |
| 12:52 ET | 200 | 54.9 |
| 12:56 ET | 3030 | 54.9 |
| 12:57 ET | 300 | 54.76 |
| 01:01 ET | 100 | 54.915 |
| 01:03 ET | 400 | 54.85 |
| 01:06 ET | 200 | 54.95 |
| 01:12 ET | 200 | 54.85 |
| 01:14 ET | 720 | 54.8 |
| 01:15 ET | 800 | 54.82 |
| 01:17 ET | 1176 | 54.96 |
| 01:19 ET | 200 | 54.97 |
| 01:24 ET | 400 | 55.22 |
| 01:26 ET | 500 | 55.2987 |
| 01:28 ET | 900 | 55.275 |
| 01:30 ET | 401 | 55.31 |
| 01:32 ET | 600 | 55.18 |
| 01:33 ET | 300 | 55.27 |
| 01:35 ET | 590 | 55.24 |
| 01:37 ET | 231 | 55.2901 |
| 01:39 ET | 700 | 55.315 |
| 01:42 ET | 300 | 55.415 |
| 01:44 ET | 2406 | 55.36 |
| 01:46 ET | 2276 | 55.445 |
| 01:48 ET | 5829 | 55.71 |
| 01:50 ET | 560 | 55.64 |
| 01:51 ET | 2900 | 55.745 |
| 01:53 ET | 900 | 55.715 |
| 01:55 ET | 3895 | 55.69 |
| 01:57 ET | 2722 | 55.665 |
| 02:00 ET | 1100 | 55.365 |
| 02:02 ET | 900 | 55.41 |
| 02:06 ET | 200 | 55.43 |
| 02:08 ET | 706 | 55.42 |
| 02:09 ET | 2600 | 55.405 |
| 02:13 ET | 500 | 55.42 |
| 02:15 ET | 1133 | 55.45 |
| 02:18 ET | 1360 | 55.44 |
| 02:20 ET | 977 | 55.37 |
| 02:22 ET | 200 | 55.33 |
| 02:24 ET | 405 | 55.44 |
| 02:26 ET | 200 | 55.46 |
| 02:27 ET | 600 | 55.535 |
| 02:29 ET | 500 | 55.52 |
| 02:31 ET | 300 | 55.46 |
| 02:33 ET | 942 | 55.5802 |
| 02:36 ET | 200 | 55.65 |
| 02:38 ET | 5200 | 55.6601 |
| 02:40 ET | 6731 | 55.67 |
| 02:42 ET | 200 | 55.64 |
| 02:44 ET | 600 | 55.83 |
| 02:45 ET | 700 | 55.8972 |
| 02:47 ET | 6319 | 55.66 |
| 02:49 ET | 200 | 55.615 |
| 02:51 ET | 900 | 55.665 |
| 02:54 ET | 1800 | 55.85 |
| 02:58 ET | 1305 | 56 |
| 03:00 ET | 2328 | 56 |
| 03:02 ET | 1200 | 55.85 |
| 03:03 ET | 600 | 55.92 |
| 03:05 ET | 500 | 55.9725 |
| 03:09 ET | 500 | 56.11 |
| 03:12 ET | 200 | 56.15 |
| 03:14 ET | 1509 | 56.18 |
| 03:16 ET | 100 | 56.23 |
| 03:18 ET | 2085 | 56.15 |
| 03:20 ET | 2905 | 56.17 |
| 03:21 ET | 122 | 56.23 |
| 03:23 ET | 1009 | 56.38 |
| 03:25 ET | 1200 | 56.46 |
| 03:27 ET | 922 | 56.45 |
| 03:30 ET | 100 | 56.4801 |
| 03:32 ET | 2358 | 56.56 |
| 03:34 ET | 5817 | 56.795 |
| 03:36 ET | 900 | 56.9 |
| 03:38 ET | 6529 | 57.01 |
| 03:39 ET | 2391 | 57 |
| 03:41 ET | 2789 | 56.95 |
| 03:43 ET | 2112 | 56.97 |
| 03:45 ET | 1200 | 57.11 |
| 03:48 ET | 681 | 57.15 |
| 03:50 ET | 5747 | 57.29 |
| 03:52 ET | 5225 | 57.13 |
| 03:54 ET | 4322 | 57.01 |
| 03:56 ET | 10688 | 56.999 |
| 03:57 ET | 6003 | 57.04 |
| 03:59 ET | 85876 | 57.09 |
Jun 24, 2022
Jun 18, 2022
INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Intra-Cellular Therapies, Inc. with Losses to Contact the Firm, from 3:31PM ET on Saturday Jun 18, 2022 by Accesswire
3:31PM ET on Saturday Jun 18, 2022 by Accesswire
Jun 16, 2022
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Intra-Cellular Therapies, Inc. with Losses to Contact the Firm, from 10:29AM ET on Thursday Jun 16, 2022 by Business Wire
10:29AM ET on Thursday Jun 16, 2022 by Business Wire
Jun 14, 2022
UBS Initiates Coverage on Intra-Cellular Therapies With Buy Rating, $75 Price Target, from 11:43AM ET on Tuesday Jun 14, 2022 by MT Newswires
11:43AM ET on Tuesday Jun 14, 2022 by MT Newswires
Jun 13, 2022
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Intra-Cellular Therapies Inc | 5.2B | -15.8x | --- |
Ascendis Pharma A/S | 4.8B | -11.4x | --- |
Apellis Pharmaceuticals Inc | 4.8B | -6.0x | --- |
Intellia Therapeutics Inc | 4.1B | -12.5x | --- |
Mirati Therapeutics Inc | 4.0B | -6.0x | --- |
Denali Therapeutics Inc | 3.8B | -13.5x | --- |
Company Information
Intra-Cellular Therapies, Inc. is a biopharmaceutical company. The Company is focused on the discovery, clinical development and commercialization of small molecule drugs that address underserved medical needs primarily in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system (CNS). The Company provides CAPLYTA (lumateperone) for the treatment of schizophrenia in adults. The CAPLYTA is a prescription medicine used to treat the depressive episodes in adults with bipolar I or II, that can be taken alone or with lithium or valproate. The Company's pipeline is focused on three platforms: lumateperone and follow-on compounds, a phosphodiesterase 1 (PDE1) inhibitor platform and discovery platform which includes ITI-333 a novel compound with high affinity at serotonin 5-HT2A, dopamine D1 and mu opioid (MOP) receptors. The Company’s subsidiaries are ITI, Inc. (ITI) and ITI Limited.
Contact Information
- Headquarters
- 430 E 29th St, 3960 BroadwayNEW YORK, NY, United States 10032
- Phone
- 212-923-3344
- Fax
- 212-923-3388
Executives
- Chairman of the Board, President, Chief Executive Officer
- Sharon Mates
- Chief Financial Officer, Senior Vice President - Finance, Treasurer, Assistant Secretary
- Lawrence Hineline
- Executive Vice President, General Counsel and Secretary
- Michael Halstead
- Executive Vice President, Chief Medical Officer
- Suresh Durgam
- Executive Vice President, Chief Commercial Officer
- Mark Neumann
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $5.2B |
|---|---|
Revenue (TTM) | $102.9M |
Shares Outstanding | 94.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.25 |
EPS | $-3.62 |
Book Value | $5.10 |
P/E Ratio | -15.8x |
Price/Sales (TTM) | 50.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -296.47% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
